Despite our data suggesting that reduced Sox9 function promotes matrix mineralization via relieved repression of Spp1, Osteopontin and Sox9 are both highly expressed in human valves excised from patients with end-stage calcific aortic valve disease [25], [33], [34], [35], [36], [37], [38]. This evidence concerns the gene SOX9 and aortic valve calcification.